Turning Ophthalmology AI Research into a Scalable Clinical Platform
Blüm Health is collaborating with AI Sight in transforming University of Liverpool research into a regulated digital health platform designed to help screening teams detect diabetic retinopathy earlier, prioritise clinical review and manage growing demand more efficiently.
AI Sight: Translating ophthalmology AI research into a regulated digital health platform
University spin-out | AI in ophthalmology | Diabetic retinopathy screening | Software as a Medical Device | Commercialisation support
Blüm Health is collaborating with AI Sight, a University of Liverpool spin-out commercialising artificial intelligence research in diabetic eye screening.
AI Sight was founded to bring a next-generation AI system from academic research into real-world use, supporting earlier identification of diabetic retinopathy and helping clinical teams manage the growing demand for eye-screening services. The technology applies machine learning to retinal images, combining human clinical expertise with machine judgement to interpret and rank images across disease severity and treatment intervention points.
Diabetic retinopathy is one of the world’s leading causes of preventable sight loss. Screening is essential because it can identify disease early enough for sight-saving interventions, but screening programmes rely on significant clinical grading capacity. This creates operational pressure for services and can introduce variability in assessment, particularly as demand continues to rise.
AI Sight is designed as an assisted grading tool that supports, rather than replaces, clinical expertise. The platform analyses digital colour fundus images and classifies diabetic retinopathy risk to help screening teams prioritise review, escalate higher-risk or uncertain cases, and manage lower-risk images more efficiently within existing clinical workflows.
Blüm Health worked with AI Sight as an end-to-end healthtech delivery partner, supporting the translation of complex academic research into a commercially viable, regulated digital health product. This included AI consultancy, software development, cloud architecture, product design and medical device regulatory compliance support.
The work involved building the technical foundations for a scalable digital health platform, including secure cloud-hosted infrastructure, image processing workflows, API connectivity, user-facing software components, administrative tools and support for clinical workflow integration.
Blüm Health also supported the development of the regulatory and quality foundations required for Software as a Medical Device, including quality management, software lifecycle processes, risk management, technical documentation, usability engineering, verification and validation planning, clinical evaluation support and DTAC compliance preparation.
Relevant capabilities
AI-enabled healthcare product development
Software as a Medical Device development
Medical device regulatory compliance
Digital health commercialisation
University spin-out support
Ophthalmology and retinal imaging technology
Machine learning deployment in healthcare
Cloud architecture and secure infrastructure
Clinical workflow integration
UX and product design for healthcare users
Quality management and technical documentation
Risk management and software lifecycle processes
DTAC and NHS readiness support
End-to-end healthtech delivery
You can find out more about the AI Sight project here
